| 1 |
33658110 | Does Systemic Isotretinoin Treatment Constitute a Predisposition to Allergic Sensitization? | 2021 |
1 |
| 2 |
33919763 | Pharmacokinetics and Safety of a Novel Oral Liquid Formulation of 13-cis Retinoic Acid in Children with Neuroblastoma: A Randomized Crossover Clinical Trial. | 2021 Apr 14 |
1 |
| 3 |
34387230 | Physeal Abnormalities in Children With High-risk Neuroblastoma Intensively Treated With/Without 13-Cis-Retinoic Acid. | 2021 Oct 1 |
1 |
| 4 |
31562833 | Isotretinoin is indirectly effective in sebocytes. | 2020 Apr |
1 |
| 5 |
31522242 | Phase I trial of belinostat in combination with 13-cis-retinoic acid in advanced solid tumor malignancies: a California Cancer Consortium NCI/CTEP sponsored trial. | 2019 Dec |
1 |
| 6 |
28786105 | Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590). | 2017 Dec 1 |
1 |
| 7 |
24858462 | Interferon alpha plus 13-cis-retinoic acid modulation of BCL-2 plus paclitaxel for recurrent small-cell lung cancer (SCLC): an Eastern Cooperative Oncology Group study (E6501). | 2014 Jul |
1 |
| 8 |
25039756 | Metabolic characteristics of 13-cis-retinoic acid (isotretinoin) and anti-tumour activity of the 13-cis-retinoic acid metabolite 4-oxo-13-cis-retinoic acid in neuroblastoma. | 2014 Dec |
3 |
| 9 |
22577058 | Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict head and neck cancer patient second primary tumor/recurrence risk and response to retinoid chemoprevention. | 2012 Jul 1 |
1 |
| 10 |
21235714 | An enzymatic mechanism for generating the precursor of endogenous 13-cis retinoic acid in the brain. | 2011 Apr |
1 |
| 11 |
21292632 | A strong case for personalized, targeted cancer prevention. | 2011 Feb |
1 |
| 12 |
21292633 | Global assessment of genetic variation influencing response to retinoid chemoprevention in head and neck cancer patients. | 2011 Feb |
1 |
| 13 |
19646277 | 13-cis-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patient phase 2 study. | 2009 Aug 1 |
1 |
| 14 |
17987264 | Retinoids induced astrocytic differentiation with down regulation of telomerase activity and enhanced sensitivity to taxol for apoptosis in human glioblastoma T98G and U87MG cells. | 2008 Mar |
1 |
| 15 |
18166465 | Improved synthesis of histone deacetylase inhibitors (HDIs) (MS-275 and CI-994) and inhibitory effects of HDIs alone or in combination with RAMBAs or retinoids on growth of human LNCaP prostate cancer cells and tumor xenografts. | 2008 Mar 15 |
1 |
| 16 |
18181979 | Decreased plasma folate concentration in young and elderly healthy subjects after a short-term supplementation with isotretinoin. | 2008 Jan |
2 |
| 17 |
17163463 | Induction of cell cycle arrest and apoptosis by a combined treatment with 13-cis-retinoic acid, interferon-alpha2a, and alpha-tocopherol in squamous cell carcinoma of the head and neck. | 2007 Apr |
1 |
| 18 |
16391896 | Combination chemotherapy with 13-cis-retinoic acid and celecoxib in the treatment of glioblastoma multiforme. | 2006 May |
1 |
| 19 |
15806132 | Pilot study of 13cis-retinoic acid+dexamethasone+alpha interferon as maintenance therapy following high-dose chemotherapy and autologous stem cell transplant for multiple myeloma. | 2005 May |
1 |
| 20 |
15961764 | Randomized phase II/III trial of interferon Alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell Carcinoma: the European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951). | 2005 Jun 20 |
1 |
| 21 |
15138569 | 13-cis retinoic acid in head and neck cancer chemoprevention: results of a randomized trial from the Italian Head and Neck Chemoprevention Study Group. | 2004 Jun |
1 |
| 22 |
15263793 | All-trans retinoic acid and interferon-alpha for treatment of human renal cell carcinoma multicellular tumor spheroids. | 2004 |
1 |
| 23 |
12643008 | A phase II study of 13-cis retinoic acid plus interferon alpha-2a in advanced stage penile carcinoma: an Eastern Cooperative Oncology Group study (E3893). | 2003 |
1 |
| 24 |
12804041 | Effects of 13-cis-retinoic acid on chemoimmunotherapy of metastatic renal cell carcinoma--results of a retrospective analysis. | 2003 Apr |
1 |
| 25 |
14581068 | Novel inhibition of cis/trans retinoic acid interconversion in biological fluids--an accurate method for determination of trans and 13-cis retinoic acid in biological fluids. | 2003 Nov 5 |
1 |
| 26 |
12168960 | Transforming growth factor-alpha: a surrogate endpoint biomarker? | 2002 Aug |
1 |
| 27 |
12389622 | Combination of 13-cis retinoic acid and interferon-alpha in the treatment of recurrent or refractory peripheral T-cell lymphoma. | 2002 Jul |
1 |
| 28 |
11408495 | Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial. | 2001 Jun 15 |
1 |
| 29 |
11505395 | Phase II evaluation of paclitaxel, alpha-interferon, and cis-retinoic acid in advanced renal cell carcinoma. | 2001 Aug 1 |
1 |
| 30 |
11509747 | Embryonic subcellular distribution of 13-cis- and all-trans-retinoic acid indicates differential cytosolic/nuclear localization. | 2001 Sep |
2 |
| 31 |
10944130 | Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinoma. | 2000 Aug |
1 |
| 32 |
11066455 | Acute promyelocytic leukemia (AML-M3)--Part 1: Pathophysiology, clinical diagnosis, and differentiation therapy. | 2000 Spring |
1 |
| 33 |
10367173 | Preliminary phase II clinical and pharmacokinetic study of 9-cis retinoic acid in advanced cervical cancer. New York Gynecologic Oncology Group. | 1999 May-Jun |
1 |
| 34 |
10378671 | Phase II study of a combination of low-dose cisplatin with 13-cis-retinoic acid and interferon-alpha in patients with advanced head and neck squamous cell carcinoma. | 1999 Apr |
1 |
| 35 |
10550153 | Placebo-controlled trial of 13-cis-retinoic acid activity on retinoic acid receptor-beta expression in a population at high risk: implications for chemoprevention of lung cancer. | 1999 Nov |
1 |
| 36 |
9806904 | Recombinant human glutathione S-transferases catalyse enzymic isomerization of 13-cis-retinoic acid to all-trans-retinoic acid in vitro. | 1998 Nov 15 |
2 |
| 37 |
9403338 | Immunosuppressive activity of 13-cis-retinoic acid in rats: aspects of pharmacokinetics and pharmacodynamics. | 1997 Oct |
1 |
| 38 |
9589358 | Effect of retinoic acid on HPV titration and colposcopic changes in Korean patients with dysplasia of the uterine cervix. | 1997 |
1 |
| 39 |
7705672 | Phase II study of 13-cis-retinoic acid plus interferon-alpha 2a in heavily pretreated squamous carcinoma of the cervix. | 1995 Mar |
1 |
| 40 |
7812199 | Differentiation therapy of myelodysplastic syndromes with retinoic acid. | 1994 Aug |
1 |
| 41 |
8439447 | 13-cis-retinoic acid affects oxidation and DNA damage in oxidative-positive SLE lymphocytes but may not be useful for therapy. | 1993 Feb |
1 |
| 42 |
8457712 | Phase II study of 13-cis-retinoic acid and interferon-alpha 2a in patients with advanced squamous cell lung cancer. | 1993 Feb |
1 |
| 43 |
1734084 | 13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin. | 1992 Feb 19 |
1 |
| 44 |
1734085 | 13-cis-retinoic acid plus interferon alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervix. | 1992 Feb 19 |
1 |
| 45 |
1918383 | Immunosuppressive activity of 13-cis-retinoic acid and prevention of experimental autoimmune encephalomyelitis in rats. | 1991 Oct |
1 |
| 46 |
2252043 | Treatment with 13-cis-retinoic acid in transfusion-dependent patients with myelodysplastic syndrome and decreased toxicity with addition of alpha-tocopherol. | 1990 Dec |
1 |
| 47 |
2522491 | Enhancement of the expression of activation markers on human peripheral blood mononuclear cells by in vitro culture with retinoids and carotenoids. | 1989 Mar |
1 |
| 48 |
3278754 | Randomized study of 13-cis retinoic acid v placebo in the myelodysplastic disorders. | 1988 Mar |
1 |
| 49 |
3320577 | Combination of low-dose cytarabine and 13-cis retinoic acid in the treatment of myelodysplastic syndromes. | 1987 |
1 |
| 50 |
6580071 | Phase I clinical trial of 13-cis-retinoic acid in myelodysplastic syndromes. | 1983 Nov |
1 |